Skip to content
Back to MMSI

Merit Medical Systems Inc

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
14
Purchases
5
Sales
9
Purchase value
$573.29K
Sale value
$9.90M

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Brian G. LloydCHIEF LEGAL OFFICER, SECRETARY
4Rule 10b5-1 plan disclosed
Filed Nov 17, 2026Period of report Nov 16, 20260001671772-26-000008
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 16, 2026
Common Stock, No Par ValueF1F216,722$86.325$1.44M60,132Direct
Filing footnotes · 6
  1. F1The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 21, 2026.
  2. F2The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.88 to $86.90, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  3. F3Become exercisable in equal annual installments of 25% commencing on 02/26/2021.
  4. F4Become exercisable in equal annual installments of 25% commencing on 03/19/2022.
  5. F5Becomes exercisable in equal annual installments of 25% commencing 02/28/2023.
  6. F6Become exercisable in equal annual installments of 25% commencing on 02/28/2024.
Open on SEC EDGAR
Neil W. PetersonCHIEF OPERATING OFFICER
4
Filed Aug 25, 2026Period of report Aug 24, 20260001926221-26-000008
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 24, 2026
Common Stock, No Par ValueF17,500$90.448$678.36K18,051Direct
Filing footnotes · 3
  1. F1The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.43 to $90.53, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  2. F2Becomes exercisable in equal annual installments of 25% commencing 08/19/2022.
  3. F3Becomes exercisable in equal annual installments of 25% commencing 2/28/2024.
Open on SEC EDGAR
Neil W. PetersonCHIEF OPERATING OFFICER
4
Filed Aug 5, 2026Period of report Aug 4, 20260001926221-26-000006
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 4, 2026
Common Stock, No Par Value21,449$85.00$1.82M25,551Direct
Filing footnotes · 2
  1. F1Becomes exercisable in equal annual installments of 25% commencing 08/19/2022.
  2. F2Becomes exercisable in equal annual installments of 25% commencing 2/28/2024.
Open on SEC EDGAR
Christian Adam SmithChief Commercial Officer
4
Filed May 13, 2026Period of report May 11, 20260002072266-26-000004
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseMay 11, 2026
Common Stock, No Par ValueF11,626$61.00$99.19K2,220IndirectBy 401(k) Plan
Filing footnotes · 3
  1. F1Represents plan holdings as of 05/11/2026.
  2. F2Become exercisable in equal annual installments of 25% commencing on 10/4/2022.
  3. F3Become exercisable in equal annual installments of 25% commencing on 3/31/2024.
Open on SEC EDGAR
Lynne N. WardDirector
4
Filed May 11, 2026Period of report May 7, 20260001786127-26-000002
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 7, 2026
Common Stock, No Par ValueF15,000$62.607$313.04K7,809Direct
Filing footnotes · 1
  1. F1The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.395 to $62.815, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Open on SEC EDGAR
Brian G. LloydCHIEF LEGAL OFFICER, SECRETARY
4
Filed May 11, 2026Period of report May 7, 20260001671772-26-000004
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseMay 7, 2026
Common Stock, No Par Value2,000$62.625$125.25K2,000IndirectBy 401 (k) plan
Filing footnotes · 4
  1. F1Become exercisable in equal annual installments of 25% commencing on 02/26/2021.
  2. F2Become exercisable in equal annual installments of 25% commencing on 03/19/2022.
  3. F3Becomes exercisable in equal annual installments of 25% commencing 02/28/2023.
  4. F4Become exercisable in equal annual installments of 25% commencing on 02/28/2024.
Open on SEC EDGAR
Raul Parra Jr.CFO AND TREASURER
4
Filed May 7, 2026Period of report May 6, 20260001742555-26-000004
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseMay 6, 2026
Common Stock, No Par Value1,500$61.01$91.52K58,843Direct
Filing footnotes · 3
  1. F1Represents plan holdings as of 05/05/2026.
  2. F2Becomes exercisable in equal annual installments of 25% commencing on 02/28/2023.
  3. F3Becomes exercisable in equal annual installments of 25% commencing on 02/28/2024.
Open on SEC EDGAR
Martha Goldberg AronsonDirector · President and CEO
4
Filed May 7, 2026Period of report May 6, 20260001429832-26-000004
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseMay 6, 2026
Common Stock, No Par Value2,000$60.44$120.88K49,792Direct
Open on SEC EDGAR
Michel J. VoigtCHIEF HUMAN RESOURCES OFFICER
4
Filed May 7, 2026Period of report May 5, 20260001836958-26-000004
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseMay 5, 2026
Common Stock, No Par ValueF12,250$60.65$136.46K2,265IndirectBy 401(k) Plan
Filing footnotes · 4
  1. F1Represents plan holdings as of 05/05/2026.
  2. F2Become exercisable in equal annual installments of 25% commencing on 03/19/2022.
  3. F3Becomes exercisable in equal annual installments of 25% commencing 02/28/2023.
  4. F4Becomes exercisable in equal annual installments of 25% commencing 2/28/2024.
Open on SEC EDGAR
Neil W. PetersonCHIEF OPERATING OFFICER
4Rule 10b5-1 plan disclosed
Filed Jan 8, 2026Period of report Jan 6, 20260001926221-26-000002
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 6, 2026
Common Stock, No Par ValueF15,000$90.00$450.00K28,369Direct
Filing footnotes · 4
  1. F1The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 6, 2024.
  2. F2Becomes exercisable in equal annual installments of 20% commencing 04/25/2020.
  3. F3Becomes exercisable in equal annual installments of 25% commencing 08/19/2022.
  4. F4Becomes exercisable in equal annual installments of 25% commencing 2/28/2024.
Open on SEC EDGAR
Fred P. LampropoulosDirector · Executive Chairman
4
Filed Nov 26, 2025Period of report Nov 25, 20250000901534-25-000011
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 25, 2025
Common Stock, No Par ValueF310,000$88.0377$880.38K1,019,955Direct
Filing footnotes · 6
  1. F1Represents securities held by the spouse of the Reporting Person. The Reporting Person expressly disclaims beneficial ownership of the securities owned by his spouse.
  2. F2The 401(k) number represents plan holdings as of 10/31/2025.
  3. F3The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.00 to $88.175, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  4. F4Becomes exercisable in equal annual installments of 25% commencing 2/26/2021.
  5. F5Becomes exercisable in equal annual installments of 25% commencing 3/19/2022.
  6. F6Becomes exercisable in equal annual installments of 25% commencing 2/28/2024.
Open on SEC EDGAR
Fred P. LampropoulosDirector · Executive Chairman
4
Filed Nov 24, 2025Period of report Nov 21, 20250000901534-25-000009
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 21, 2025
Common Stock, No Par ValueF325,000$87.31$2.18M1,029,955Direct
Filing footnotes · 6
  1. F1Represents securities held by the spouse of the Reporting Person. The Reporting Person expressly disclaims beneficial ownership of the securities owned by his spouse.
  2. F2The 401(k) number represents plan holdings as of 10/31/2025.
  3. F3The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.0000 to $87.6708, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  4. F4Becomes exercisable in equal annual installments of 25% commencing 2/26/2021.
  5. F5Becomes exercisable in equal annual installments of 25% commencing 3/19/2022.
  6. F6Becomes exercisable in equal annual installments of 25% commencing 2/28/2024.
Open on SEC EDGAR
Fred P. LampropoulosDirector · Executive Chairman
4
Filed Nov 21, 2025Period of report Nov 20, 20250000901534-25-000007
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 20, 2025
Common Stock, No Par ValueF320,000$85.1325$1.70M1,054,955Direct
Filing footnotes · 6
  1. F1Represents securities held by the spouse of the Reporting Person. The Reporting Person expressly disclaims beneficial ownership of the securities owned by his spouse.
  2. F2The 401(k) number represents plan holdings as of 10/31/2025.
  3. F3The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.01 to $86.3499, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  4. F4Becomes exercisable in equal annual installments of 25% commencing 2/26/2021.
  5. F5Becomes exercisable in equal annual installments of 25% commencing 3/19/2022.
  6. F6Becomes exercisable in equal annual installments of 25% commencing 2/28/2024.
Open on SEC EDGAR
Fred P. LampropoulosDirector · Executive Chairman
4
Filed Nov 20, 2025Period of report Nov 18, 20250000901534-25-000005
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 18, 2025
Common Stock, No Par ValueF35,000$84.826$424.13K1,074,955Direct
Filing footnotes · 6
  1. F1Represents securities held by the spouse of the Reporting Person. The Reporting Person expressly disclaims beneficial ownership of the securities owned by his spouse.
  2. F2The 401(k) number represents plan holdings as of 10/31/2025.
  3. F3The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.03 to $86.44, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  4. F4Becomes exercisable in equal annual installments of 25% commencing 2/26/2021.
  5. F5Becomes exercisable in equal annual installments of 25% commencing 3/19/2022.
  6. F6Becomes exercisable in equal annual installments of 25% commencing 2/28/2024.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.